Cell-free DNA Analysis for Noninvasive Examination of Trisomy
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Cell-free DNA (cfDNA) testing for fetal trisomy is highly effective among high-risk women. However, there have been few direct, well-powered studies comparing cfDNA testing with standard screening during the first trimester in routine prenatal populations. METHODS: In this prospective, multicenter, blinded study conducted at 35 international centers, we assigned pregnant women presenting for aneuploidy screening at 10 to 14 weeks of gestation to undergo both standard screening (with measurement of nuchal translucency and biochemical analytes) and cfDNA testing. Participants received the results of standard screening; the results of cfDNA testing were blinded. Determination of the birth outcome was based on diagnostic genetic testing or newborn examination. The primary outcome was the area under the receiver-operating-characteristic curve (AUC) for trisomy 21 (Down's syndrome) with cfDNA testing versus standard screening. We also evaluated cfDNA testing and standard screening to assess the risk of trisomies 18 and 13. RESULTS: Of 18,955 women who were enrolled, results from 15,841 were available for analysis. The mean maternal age was 30.7 years, and the mean gestational age at testing was 12.5 weeks. The AUC for trisomy 21 was 0.999 for cfDNA testing and 0.958 for standard screening (P=0.001). Trisomy 21 was detected in 38 of 38 women (100%; 95% confidence interval [CI], 90.7 to 100) in the cfDNA-testing group, as compared with 30 of 38 women (78.9%; 95% CI, 62.7 to 90.4) in the standard-screening group (P=0.008). False positive rates were 0.06% (95% CI, 0.03 to 0.11) in the cfDNA group and 5.4% (95% CI, 5.1 to 5.8) in the standard-screening group (P<0.001). The positive predictive value for cfDNA testing was 80.9% (95% CI, 66.7 to 90.9), as compared with 3.4% (95% CI, 2.3 to 4.8) for standard screening (P<0.001). CONCLUSIONS: In this large, routine prenatal-screening population, cfDNA testing for trisomy 21 had higher sensitivity, a lower false positive rate, and higher positive predictive value than did standard screening with the measurement of nuchal translucency and biochemical analytes. (Funded by Ariosa Diagnostics and Perinatal Quality Foundation; NEXT ClinicalTrials.gov number, NCT01511458.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, cfDNA analysis has been useful for non-invasive prenatal testing applications, such as for the identification of trisomy 21 (ref.124).”
From Clinical metagenomics (2019) · cites this paper as [124]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
First-Trimester or Second-Trimester Screening, or Both, for Down's Syndrome
Malone, F. D., Canick, J. A., Ball, R. H., Nyberg, D. A., Comstock, C. H., Bukowski, R., Berkowitz, R. L., Gross, S. J., Dugoff, L., Craigo, S. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043693 · Cited by 1,081
Palomaki, G. E., Kloza, E. M., Lambert-Messerlian, G. M., Haddow, J. E., Neveux, L. M., Ehrich, M., van den Boom, D., Bombard, A. T., Deciu, C., Grody, W. W., et al. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3182368a0e · Cited by 939
Gil, M. M., Quezada, M. S., Revello, R., Akolekar, R., & Nicolaides, K. H. (2015) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.14791 · Cited by 807
Akolekar, R., Beta, J., Picciarelli, G., Ogilvie, C., & D'Antonio, F. (2015) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.14636 · Cited by 711
Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population
Nicolaides, K. H., Syngelaki, A., Ashoor, G., Birdir, C., & Touzet, G. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.08.033 · Cited by 624
DNA Sequencing versus Standard Prenatal Aneuploidy Screening
Bianchi, D. W., Parker, R. L., Wentworth, J., Madankumar, R., Saffer, C., Das, A. F., Craig, J. A., Chudova, D. I., Devers, P. L., Jones, K. W., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311037 · Cited by 620
Norton, M. E., Brar, H., Weiss, J., Karimi, A., Laurent, L. C., Caughey, A. B., Rodriguez, M. H., Williams, J., Mitchell, M. E., Adair, C. D., et al. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.05.021 · Cited by 596
Self-citationFirst-Trimester Screening for Trisomies 21 and 18
Wapner, R., Thom, E., Simpson, J. L., Pergament, E., Silver, R., Filkins, K., Platt, L., Mahoney, M., Johnson, A., Hogge, W. A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025273 · Cited by 563
Self-citationDNA Sequencing Versus Standard Prenatal Aneuploidy Screening
Rochon, M. L. (2014) · Cited by 468
Cited by
Items 101–200 of 817
Palomaki, G. E., & Kloza, E. M. (2018) · Genetics in Medicine · doi:10.1038/gim.2018.22 · Cited by 65
Kater‐Kuipers, A., Bunnik, E. M., de Beaufort, I. D., & Galjaard, R. J. H. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-018-2050-4 · Cited by 72
Chan, N., Smet, M., Sandow, R., Costa, F. D. S., & McLennan, A. (2017) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.15006 · Cited by 67
A multiplex droplet digital PCR assay for non-invasive prenatal testing of fetal aneuploidies
Tan, C., Chen, X., Wang, F., Wang, D., Cao, Z., Zhu, X., Lu, C., Yang, W., Gao, N., Gao, H., et al. (2019) · The Analyst · doi:10.1039/c8an02018c · Cited by 63
Drag, M., & Kilpeläinen, T. O. (2020) · Physiological Genomics · doi:10.1152/physiolgenomics.00086.2020 · Cited by 59
Krishna, I., Badell, M. L., Loucks, T. L., Lindsay, M. K., & Samuel, A. (2016) · Prenatal Diagnosis · doi:10.1002/pd.4779 · Cited by 56
Cell-Free Fetal DNA Testing for Prenatal Diagnosis
Drury, S. C., Hill, M. K., & Chitty, L. S. (2016) · Advances in clinical chemistry · doi:10.1016/bs.acc.2016.05.004 · Cited by 60
Miltoft, C. B., Rode, L., Ekelund, C. K., Sundberg, K., Kjærgaard, S., Zingenberg, H., & Tabor, A. (2017) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.17562 · Cited by 56
Ethical considerations in prenatal testing: Genomic testing and medical uncertainty
Richardson, A., & Ormond, K. E. (2017) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2017.10.001 · Cited by 63
Expanding non‐invasive prenatal testing beyond chromosomes 21, 18, 13, X and Y
BENN, P. A. (2016) · Clinical Genetics · doi:10.1111/cge.12818 · Cited by 56
Phillips, K. A., Deverka, P. A., Sox, H. C., Khoury, M. J., Sandy, L. G., Ginsburg, G. S., Tunis, S. R., Orlando, L. A., & Douglas, M. P. (2017) · Genetics in Medicine · doi:10.1038/gim.2017.21 · Cited by 55
The importance of determining the limit of detection of non‐invasive prenatal testing methods
Fiorentino, F., Bono, S., Pizzuti, F., Mariano, M., Polverari, A., Duca, S., Sessa, M., Baldi, M., Diano, L., & Spinella, F. (2016) · Prenatal Diagnosis · doi:10.1002/pd.4780 · Cited by 56
Lewis, C., Hill, M. K., & Chitty, L. S. (2017) · Prenatal Diagnosis · doi:10.1002/pd.5154 · Cited by 61
Schmid, M. P., Klaritsch, P., Arzt, W., Burkhardt, T., Duba, H., Haeusler, M. C. H., Hafner, E., Lang, U. E., Pertl, B., Speicher, M. R., et al. (2015) · Ultraschall in der Medizin - European Journal of Ultrasound · doi:10.1055/s-0035-1553804 · Cited by 54
BENN, P. A., Curnow, K. J., Chapman, S., Michalopoulos, S. N., Hornberger, J. C., & Rabinowitz, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132313 · Cited by 52
Prenatal Testing in the Genomic Age: Clinical Outcomes, Quality of Life, and Costs
Kaimal, A. J., Norton, M. E., & Kuppermann, M. (2015) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000001029 · Cited by 57
Self-citationLewis, C., Hill, M. K., & Chitty, L. S. (2016) · Prenatal Diagnosis · doi:10.1002/pd.4879 · Cited by 52
Hovelson, D. H., Liu, C., Wang, Y., Kang, Q., Henderson, J., Gursky, A. M., Brockman, S., Ramnath, N., Krauss, J. C., Talpaz, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21163 · Cited by 57
Liu, Y., Liu, H., He, Y., Xu, W., Ma, Q., He, Y., Lei, W., Chen, G., He, Z., Huang, J., et al. (2020) · Human Genomics · doi:10.1186/s40246-020-00268-2 · Cited by 53
Sonek, J., Kagan, K. O., & Nicolaides, K. H. (2016) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2016.01.009 · Cited by 58
Sequencing shorter cfDNA fragments improves the fetal DNA fraction in noninvasive prenatal testing
Qiao, L., Yu, B., Liang, Y., Zhang, C., Wu, X., Xue, Y., Shen, C., He, Q., Lu, J., Xiang, J., et al. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.05.023 · Cited by 56
Deng, C., Zhu, Q., Liu, S., Liu, J., Bai, T., Jing, X., Xia, T., Liu, Y., Cheng, J., Li, Z., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-44018-4 · Cited by 55
Gekas, J., Langlois, S., Ravitsky, V., Audibert, F., Berg, D. V. D., Haidar, H., & Rousseau, F. (2016) · The Application of Clinical Genetics · doi:10.2147/tacg.s85361 · Cited by 70
Non-invasive prenatal diagnosis of thalassemias using maternal plasma cell free DNA
Hudecova, I., & Chiu, R. W. K. (2016) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2016.10.016 · Cited by 53
Farrell, R. M., Agatisa, P. K., Mercer, M. B., Mitchum, A., & Coleridge, M. B. (2016) · Prenatal Diagnosis · doi:10.1002/pd.4812 · Cited by 49
Kagan, K. O., Sroka, F., Sonek, J., Abele, H., Lüthgens, K., Schmid, M., Wagner, P., Brucker, S. Y., Wallwiener, D. R., & Hoopmann, M. (2018) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.18905 · Cited by 55
Current Advancements in Noninvasive Profiling of the Embryo Culture Media Secretome
Zmuidinaite, R., Sharara, F. I., & Iles, R. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052513 · Cited by 54
Prenatal cfDNA Sequencing and Incidental Detection of Maternal Cancer
Turriff, A. E., Annunziata, C. M., Malayeri, A. A., Redd, B. A., Pavelova, M., Goldlust, I. S., Rajagopal, P. S., Lin, J., & Bianchi, D. W. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2401029 · Cited by 48
Ethical considerations of gene editing and genetic selection
Rothschild, J. (2020) · Journal of General and Family Medicine · doi:10.1002/jgf2.321 · Cited by 59
BENN, P. A., Valenti, E., Shah, S. S., Martin, K. A., & Demko, Z. (2018) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002728 · Cited by 49
Conte, G. L., Letourneau, A., Jani, J. C., Kleinfinger, P., Lohmann, L., Costa, J., & Benachi, A. (2017) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.18838 · Cited by 49
Lewis, J. M., Heineck, D. P., & Heller, M. J. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1069709 · Cited by 52
Novel window on early human neurodevelopment via fetal exosomes in maternal blood
Goetzl, L. M., Darbinian, N., & Goetzl, E. J. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.296 · Cited by 52
Overall evaluation of the clinical value of prenatal screening for fetal-free DNA in maternal blood
Yu, B., Lu, B., Zhang, B., Zhang, X., Chen, Y.-P., Zhou, Q., Jiang, J. W., & Wang, H. (2017) · Medicine · doi:10.1097/md.0000000000007114 · Cited by 44
Aneuploidy Screening in Pregnancy
Dashe, J. S. (2016) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000001385 · Cited by 43
Huang, C.-E., Ma, G., Jou, H., Lin, W., Lee, D.-J., Lin, Y.-S., Ginsberg, N. A., Chen, H., Chang, F. M.-C., & Chen, M. (2017) · Molecular Cytogenetics · doi:10.1186/s13039-017-0343-3 · Cited by 43
McKanna, T. A., Ryan, A., Krinshpun, S., Kareht, S., Marchand, K. F., Grabarits, C., Ali, M., McElheny, A., Gardiner, K., LeChien, K. A., et al. (2018) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.19176 · Cited by 48
Kostenko, E., Chantraine, F., Vandeweyer, K., Schmid, M., Lefevre, A., Hertz, D. S., Zelle, L., Bartha, J. L., & Renzo, G. C. D. (2018) · Fetal Diagnosis and Therapy · doi:10.1159/000491750 · Cited by 43
Wang, C., Tang, J., Tong, K., Huang, D., Tu, H., Li, Q., & Zhu, J. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-01131-6 · Cited by 49
(2019) · Europe PMC (PubMed Central) · Cited by 65
Zhang, L., Dong, D., Sun, Y., Hu, C., Sun, C., Wu, Q., & Tian, J. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.17854 · Cited by 42
Suzumori, N., Sekizawa, A., Takeda, E., Samura, O., Sasaki, A., Akaishi, R., Wada, S., Hamanoue, H., Hirahara, F., Kuriki, H., et al. (2018) · Prenatal Diagnosis · doi:10.1002/pd.5408 · Cited by 42
Robson, S., & Hui, L. (2015) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12380 · Cited by 41
McLennan, A., Palma-Dias, R. S., Costa, F. D. S., Meagher, S. E., Nisbet, D., & Scott, F. (2016) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12432 · Cited by 45
Zhang, H., Yang, Y., Li, X., Shi, Y., Hu, B., An, Y., Zhu, Z., Hong, G., & Yang, C. J. (2018) · Lab on a Chip · doi:10.1039/c8lc00650d · Cited by 41
Kadji, C., Cannie, M., Resta, S., Guez, D., Abi-Khalil, F., Angelis, R. D., & Jani, J. C. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.12.031 · Cited by 72
van der Meij, K. R. M., der Mooren, M. D. D. G.-V., Carbo, E. W. S., Pieters, M. J., Rodenburg, W., Sistermans, E. A., Cornel, M. C., & Henneman, L. (2021) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14091 · Cited by 46
Scheffer, P. G., Wirjosoekarto, S. A. M., Becking, E. C., Weiss, M. M., Bax, C. J., Oepkes, D., Sistermans, E. A., Henneman, L., & Bekker, M. N. (2021) · Prenatal Diagnosis · doi:10.1002/pd.6028 · Cited by 44
Johnston, M., Warton, C., Pertile, M. D., Taylor-Sands, M. M., Delatycki, M. B., Hui, L., Savulescu, J., & Mills, C. (2022) · Prenatal Diagnosis · doi:10.1002/pd.6217 · Cited by 47
Noninvasive Prenatal Testing Using Circulating DNA and RNA: Advances, Challenges, and Possibilities
Moufarrej, M. N., Bianchi, D. W., Shaw, G. M., Stevenson, D. K., & Quake, S. R. (2023) · Annual Review of Biomedical Data Science · doi:10.1146/annurev-biodatasci-020722-094144 · Cited by 48
Palomaki, G. E., Kloza, E. M., O’Brien, B. M., Eklund, E. E., & Lambert-Messerlian, G. M. (2017) · Genetics in Medicine · doi:10.1038/gim.2016.194 · Cited by 42
Advani, H. V., Barrett, A. N., Evans, M. I., & Choolani, M. A. (2017) · Prenatal Diagnosis · doi:10.1002/pd.5161 · Cited by 42
Soster, E. L., Boomer, T., Hicks, S. C., Caldwell, S., Dyr, B., Chibuk, J., & Almasri, E. (2021) · Genetics in Medicine · doi:10.1038/s41436-021-01135-8 · Cited by 39
Xu, C., Li, J., Chen, S., Cai, X., Jing, R., Qin, X., Pan, D., Zhao, X., Ma, D., Xu, X., et al. (2022) · Cell Discovery · doi:10.1038/s41421-022-00457-4 · Cited by 44
Valderramos, S. G., Rao, R., Scibetta, E. W., Silverman, N. S., Han, C. S., & Platt, L. D. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.06.039 · Cited by 38
Prenatal Screening for 22q11.2 Deletion Using a Targeted Microarray-Based Cell-Free DNA Test
Schmid, M., Wang, E., Bogard, P. E., Bevilacqua, E., Hacker, C., Wang, S., Doshi, J., White, K., Kaplan, J., Sparks, A. B., et al. (2017) · Fetal Diagnosis and Therapy · doi:10.1159/000484317 · Cited by 38
Chitty, L. S., Hudgins, L., & Norton, M. E. (2018) · Prenatal Diagnosis · doi:10.1002/pd.5216 · Cited by 43
Self-citationChang, M. Y., Ahn, S., Kim, M. Y., Han, J. H., Park, H.-R., Seo, H. K., Yoon, J., Lee, S., Oh, D., Kang, C. P., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21236-w · Cited by 38
Detection of cryptogenic malignancies from metagenomic whole genome sequencing of body fluids
Gu, W., Talevich, E., Hsu, E. D., Qi, Z., Urisman, A., Federman, S. M., Gopez, A., Arevalo, S., Gottschall, M., Liao, L., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00912-z · Cited by 37
Dobson, L. J., Reiff, E. S., Little, S. E., Wilkins-Haug, L. E., & Bromley, B. (2016) · Prenatal Diagnosis · doi:10.1002/pd.4805 · Cited by 37
Reproducibility of Digital PCR Assays for Circulating Tumor DNA Analysis in Advanced Breast Cancer
Hrebien, S., O’Leary, B., Beaney, M., Schiavon, G., Fribbens, C. V., Bhambra, A., Johnson, R., García-Murillas, I., & Turner, N. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165023 · Cited by 40
Turner syndrome: New insights from prenatal genomics and transcriptomics
Bianchi, D. W. (2019) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31675 · Cited by 37
Yuan, X., Zhou, L., Zhang, B., Wang, H., Yu, B., & Xu, J. (2020) · Pregnancy Hypertension · doi:10.1016/j.preghy.2020.07.015 · Cited by 40
Becking, E. C., Wirjosoekarto, S. A. M., Scheffer, P. G., Huiskes, J. V. M., Remmelink, M. J., Sistermans, E. A., Bax, C. J., Weiss, M. M., Henneman, L., & Bekker, M. N. (2021) · Prenatal Diagnosis · doi:10.1002/pd.6034 · Cited by 41
BENN, P. A. (2016) · Journal of Fetal Medicine · doi:10.1007/s40556-016-0109-8 · Cited by 36
Xue, H., Yu, A., Lin, M., Chen, X., Guo, Q., Xu, L., & Huang, H. (2022) · Scientific Reports · doi:10.1038/s41598-022-24337-9 · Cited by 46
Artieri, C. G., Haverty, C. E., Evans, E. A., Goldberg, J. D., Haque, I. S., Yaron, Y., & Muzzey, D. (2017) · Prenatal Diagnosis · doi:10.1002/pd.5036 · Cited by 39
Vora, N. L., Robinson, S., Hardisty, E., & Stamilio, D. M. (2016) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.15995 · Cited by 36
Wei, X., Cai, B., Chen, K., Cheng, L., Zhu, Y., Wang, Z., Sun, Y., Liu, W., Guo, S., Zhang, Y., et al. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2018.10.027 · Cited by 36
Sahlin, E., Nordenskjöld, M., Gustavsson, P., Wincent, J., Georgsson, S., & Iwarsson, E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156088 · Cited by 45
Shani, H., Goldwaser, T., Keating, J., & Klugman, S. D. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.12.025 · Cited by 35
Genetic architecture and risk prediction of gestational diabetes mellitus in Chinese pregnancies
Gu, Y., Zheng, H., Wang, P., Liu, Y., Guo, X., Wei, Y., Yang, Z., Cheng, S., Chen, Y., Hu, L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59442-6 · Cited by 46
Noninvasive Prenatal Testing - When Is It Advantageous to Apply
Liehr, T., Lauten, A., Schneider, U., Schleußner, E., & Weise, A. (2017) · Biomedicine Hub · doi:10.1159/000458432 · Cited by 35
Pandora's pregnancy: NIPT, CMA, and genome sequencing—A new era for prenatal genetic testing
Hashiloni‐Dolev, Y., Nov‐Klaiman, T., & Raz, A. E. (2019) · Prenatal Diagnosis · doi:10.1002/pd.5495 · Cited by 36
Circulating Cell Free DNA in the Diagnosis of Trophoblastic Tumors
Openshaw, M. R., Harvey, R. A., Sebire, N. J., Kaur, B. S., Sarwar, N., Seckl, M. J., & Fisher, R. A. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.12.022 · Cited by 35
Adherence of cell-free DNA noninvasive prenatal screens to ACMG recommendations
Skotko, B. G., Allyse, M. A., Bajaj, K., Best, R. G., Klugman, S. D., W.Leach, M., Meredith, S., Michie, M., Stoll, K. A., & Gregg, A. R. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0485-2 · Cited by 35
Non-invasive prenatal testing: use of cell-free fetal DNA in Down syndrome screening
Rafi, I., Hill, M. K., Hayward, J., & Chitty, L. S. (2017) · British Journal of General Practice · doi:10.3399/bjgp17x691625 · Cited by 35
Hong, J. G. S., & Kumar, S. (2023) · Clinical Science · doi:10.1042/cs20220300 · Cited by 47
Preeclampsia risk prediction from prenatal cell-free DNA screening
Adil, M., Kolarova, T. R., Doebley, A.-L., Chen, L. A., Tobey, C. L., Galipeau, P. C., Rosen, S., Yang, M., Colbert, B. G., Patton, R. D., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03509-w · Cited by 45
Maternal Plasma DNA and RNA Sequencing for Prenatal Testing
Tamminga, S., van Maarle, M. C., Henneman, L., Oudejans, C. B. M., Cornel, M. C., & Sistermans, E. A. (2016) · Advances in clinical chemistry · doi:10.1016/bs.acc.2015.12.004 · Cited by 39
Genomic futures of prenatal screening: ethical reflection
Dondorp, W., Christiaens, G. C. M. L., & de Wert, G. M. W. R. (2015) · Clinical Genetics · doi:10.1111/cge.12640 · Cited by 34
Tamminga, S., van Schendel, R. V., Rommers, W., Bilardo, C. M., Pajkrt, E., Dondorp, W., van Maarle, M. C., Cornel, M. C., & Henneman, L. (2015) · Prenatal Diagnosis · doi:10.1002/pd.4697 · Cited by 44
Suzumori, N., Sekizawa, A., Ebara, T., Samura, O., Sasaki, A., Akaishi, R., Wada, S., Hamanoue, H., Hirahara, F., Izumi, H., et al. (2018) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2018.03.048 · Cited by 35
Early second-trimester plasma cell free DNA levels with subsequent risk of pregnancy complications
Yuan, X., Zhou, L., Zhang, B., Wang, H., Jiang, J. W., & Yu, B. (2019) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2019.07.001 · Cited by 37
Technological readiness and implementation of genomic‐driven precision medicine for complex diseases
Franks, P. W., Melén, E., Friedman, M., Sundström, J., Kockum, I. S., Klareskog, L., Almqvist, C., Bergen, S. E., Czene, K., Hägg, S., et al. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13330 · Cited by 53
Self-citationDe Franco, E., Caswell, R., Houghton, J. A. L., Iotova, V., Hattersley, A. T., & Ellard, S. (2017) · Diabetic Medicine · doi:10.1111/dme.13180 · Cited by 31
Zaami, S., Orrico, A., Signore, F., Cavaliere, A. F., Mazzi, M., & Marinelli, E. (2021) · Genes · doi:10.3390/genes12020204 · Cited by 41
Noninvasive prenatal screening for fetal sex chromosome aneuploidies
Deng, C., Cheung, S. W., & Liu, H. (2021) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2021.1911651 · Cited by 32
Clinical impacts of genome-wide noninvasive prenatal testing for rare autosomal trisomy
Xiang, J., Li, R., He, J., Wang, X., Yao, L., Song, N., Fu, F., Zhou, S., Wang, J., Gao, X., et al. (2022) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2022.100790 · Cited by 33
Clinical, social and ethical issues associated with non-invasive prenatal testing for aneuploidy
Griffin, B., Edwards, S., Chitty, L. S., & Lewis, C. (2017) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.1080/0167482x.2017.1286643 · Cited by 37
Noninvasive prenatal testing: from aneuploidy to single genes
Guseh, S. H. (2019) · Human Genetics · doi:10.1007/s00439-019-02061-1 · Cited by 33
Alu cell-free DNA concentration, Alu index, and LINE-1 hypomethylation as a cancer predictor
Park, M., Lee, J.-C., Lee, J., & Hwang, S. (2021) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2021.04.021 · Cited by 31
A Deep-Learning-Based Method Can Detect Both Common and Rare Genetic Disorders in Fetal Ultrasound
Tang, J., Han, J., Xue, J., Zhen, L., Yang, X., Pan, M., Hu, L., Li, R., Jiang, Y., Zhang, Y., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11061756 · Cited by 40
Floyd, E. G., Allyse, M. A., & Michie, M. (2016) · Journal of Genetic Counseling · doi:10.1007/s10897-015-9928-3 · Cited by 33
Fetal therapy for Down syndrome: an ethical exploration
de Wert, G. M. W. R., Dondorp, W., & Bianchi, D. W. (2016) · Prenatal Diagnosis · doi:10.1002/pd.4995 · Cited by 29
Martin, L., der Wal, J. T. G.-V., de Boer, M. A., Vanstone, M. G., & Henneman, L. (2017) · Midwifery · doi:10.1016/j.midw.2017.09.008 · Cited by 36
Precision Medicine in Obesity and Type 2 Diabetes: The Relevance of Early-Life Exposures
Estampador, A. C., & Franks, P. W. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2017.273540 · Cited by 34
Non-invasive Prenatal Testing and the Unveiling of an Impaired Translation Process
Murdoch, B., Ravitsky, V., Ogbogu, U., Ali‐Khan, S. E., Bertier, G., Birko, S., Bubela, T. M., de Beer, J., Dupras, C., Ellis, M., et al. (2016) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2016.09.004 · Cited by 36
Non-Invasive Prenatal Testing beyond Trisomies
Suciu, I. D., Toader, O. D., Galeva, S., & Pop, L. G. (2019) · Journal of Medicine and Life · doi:10.25122/jml-2019-0053 · Cited by 37
Chen, Y., Lai, Y., Xu, F., Qin, H., Tang, Y., Huang, X., Meng, L., Su, J., Sun, W., Shen, Y., et al. (2021) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2021.1907333 · Cited by 31
Metadata
- Authors
- Norton, M. E., Jacobsson, B., Swamy, G. K., Laurent, L. C., Ranzini, A. C., Brar, H., Tomlinson, M. W., Pereira, L., Spitz, J. L., Hollemon, D., Cuckle, H., Musci, T. J., & Wapner, R. J.
- Affiliations
- Saint Peter's University Hospital (US)
- Sahlgrenska University Hospital (SE)
- Duke University (US)
- University of California San Diego (US)
- Oregon Health & Science University (US)
- Perinatal Quality Foundation (US)
- Columbia University (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-04-23
- Volume
- 372
- Issue
- 17
- Pages
- 1589-1597
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2139926668
- Cited by
- 817
- References
- 32
- Citations by year
- 2026: 33 · 2025: 39 · 2024: 50 · 2023: 59 · 2022: 61 · 2021: 86 · 2020: 72 · 2019: 74 · 2018: 73 · 2017: 86 · 2016: 107 · 2015: 75
- FWCI
- 113.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Västra Götalandsregionen
- Thomas Jefferson University
- University of California, San Diego
- University of California, San Francisco
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
- Health Sciences › Medicine › Obstetrics and Gynecology › Maternal and Perinatal Health Interventions
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Assisted Reproductive Technology and Twin Pregnancy
- Keywords
- cell-free DNA, prenatal aneuploidy screening, Down syndrome, trisomy 18, trisomy 13, first-trimester screening, nuchal translucency, biochemical analytes, diagnostic accuracy, false positive rate, positive predictive value, non-invasive prenatal testing, maternal age
- MeSH terms
- Adolescent, Adult, Chromosome Aberrations, DNA, Down Syndrome, False Positive Reactions, Female, Fetus, Humans, Middle Aged, Pregnancy, Pregnancy Trimester, First, Prenatal Diagnosis, Prospective Studies, Sensitivity and Specificity, Single-Blind Method, Area Under Curve, Nuchal Translucency Measurement, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.